[go: up one dir, main page]

WO1998000119A3 - Verwendungen von wirkstoffen, welche die funktionen von nicht-neuronalem acetylcholin beeinflussen - Google Patents

Verwendungen von wirkstoffen, welche die funktionen von nicht-neuronalem acetylcholin beeinflussen Download PDF

Info

Publication number
WO1998000119A3
WO1998000119A3 PCT/EP1997/003415 EP9703415W WO9800119A3 WO 1998000119 A3 WO1998000119 A3 WO 1998000119A3 EP 9703415 W EP9703415 W EP 9703415W WO 9800119 A3 WO9800119 A3 WO 9800119A3
Authority
WO
WIPO (PCT)
Prior art keywords
applications
functions
neuronal acetylcholine
active substances
non neuronal
Prior art date
Application number
PCT/EP1997/003415
Other languages
English (en)
French (fr)
Other versions
WO1998000119A2 (de
Inventor
Ignaz Wessler
Original Assignee
Boehringer Ingelheim Kg
Boehringer Ingelheim Int
Ignaz Wessler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg, Boehringer Ingelheim Int, Ignaz Wessler filed Critical Boehringer Ingelheim Kg
Priority to AU32632/97A priority Critical patent/AU3263297A/en
Publication of WO1998000119A2 publication Critical patent/WO1998000119A2/de
Publication of WO1998000119A3 publication Critical patent/WO1998000119A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Verfahren zur Bestimmung des Funktionszustandes von nicht-neuronalem Acetylcholin in direkt oder endoskopisch zugänglichem humanen Geweben oder Zellen sowie die Verwendung von Wirkstoffen, mit denen die Synthese, Freisetzung, Inaktivierung und die Funktion von nicht-neuronalem Acetylcholin beeinflußt werden kann.
PCT/EP1997/003415 1996-07-02 1997-07-01 Verwendungen von wirkstoffen, welche die funktionen von nicht-neuronalem acetylcholin beeinflussen WO1998000119A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU32632/97A AU3263297A (en) 1996-07-02 1997-07-01 New use of active ingredients which affect non-neuronal acetylcholine functions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19626373.5 1996-07-02
DE19626373A DE19626373A1 (de) 1996-07-02 1996-07-02 Neuartige Verwendung von Wirkstoffen, welche die Funktion von nichtneuronalem Acetylcholin beeinflussen

Publications (2)

Publication Number Publication Date
WO1998000119A2 WO1998000119A2 (de) 1998-01-08
WO1998000119A3 true WO1998000119A3 (de) 1998-04-02

Family

ID=7798569

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/003415 WO1998000119A2 (de) 1996-07-02 1997-07-01 Verwendungen von wirkstoffen, welche die funktionen von nicht-neuronalem acetylcholin beeinflussen

Country Status (4)

Country Link
AU (1) AU3263297A (de)
DE (1) DE19626373A1 (de)
WO (1) WO1998000119A2 (de)
ZA (1) ZA975804B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8742198A (en) * 1997-08-15 1999-03-08 Shire International Licensing B.V. Use of cholinesterase inhibitor for treating diseases associated with pro teolytic enzyme activity
GB9918760D0 (en) * 1999-08-09 1999-10-13 Darwin Discovery Ltd Topical treatment
US6277855B1 (en) * 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
DE10111843A1 (de) 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von inflammatorischen Erkrankungen
US20050142088A1 (en) * 2002-02-07 2005-06-30 Mitsuru Mizuno Hair growth stimulants, percutaneous preparations and method of stimulating hair growth
WO2005072713A2 (en) * 2004-01-27 2005-08-11 The Feinstein Institute For Medical Research Cholinesterase inhibitors for treating inflammation
GB2419093A (en) * 2004-10-12 2006-04-19 Ernir Snorrason Acetylcholinesterase inhibitors for the treatment of skin
EP2008660A1 (de) * 2004-10-12 2008-12-31 Ernir Snorrason Verfahren zur Behandlung von Hauterkrankungen
TR201802725T4 (tr) 2013-03-15 2018-03-21 Verona Pharma Plc İlaç kombinasyonu.
US20190125734A1 (en) * 2016-05-09 2019-05-02 Nanoegg Research Laboratories, Inc. Composition for treating or preventing atopic dermatitis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1243729A1 (ru) * 1984-06-01 1986-07-15 Киевский государственный институт усовершенствования врачей Способ лечени нейродермита
US5084281A (en) * 1989-02-14 1992-01-28 Dillon Richard S Method and solution for treating tissue wounds
EP0534343A1 (de) * 1991-09-23 1993-03-31 Hoechst-Roussel Pharmaceuticals Incorporated Substituierte Pyridinylamino-1H-Indole, 1-H-Indazole, 2H-Indazole, Benzo(b)thiphen und 1,2-Benzisothiazole, Verfahren zu ihren Herstellung und ihre Verwendung als Arzneimittel
WO1994015623A1 (en) * 1992-12-30 1994-07-21 Patent Biopharmaceutics Inc. Hyaluronic acid-urea pharmaceutical compositions and uses

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1243729A1 (ru) * 1984-06-01 1986-07-15 Киевский государственный институт усовершенствования врачей Способ лечени нейродермита
US5084281A (en) * 1989-02-14 1992-01-28 Dillon Richard S Method and solution for treating tissue wounds
EP0534343A1 (de) * 1991-09-23 1993-03-31 Hoechst-Roussel Pharmaceuticals Incorporated Substituierte Pyridinylamino-1H-Indole, 1-H-Indazole, 2H-Indazole, Benzo(b)thiphen und 1,2-Benzisothiazole, Verfahren zu ihren Herstellung und ihre Verwendung als Arzneimittel
WO1994015623A1 (en) * 1992-12-30 1994-07-21 Patent Biopharmaceutics Inc. Hyaluronic acid-urea pharmaceutical compositions and uses

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE Dialog Information Services; XP002047242 *
DATABASE WPI Section Ch Week 8710, Derwent World Patents Index; Class B05, AN 87-071007, XP002047243 *
EVANS S. ET AL: "Synthesis and release of acetylcholine in the rabbit kidney cortex", LIFE SCI. (ENGLAND), vol. 51, no. 22, 1992, pages 1699 - 1703, XP002047239 *
GAJEWAKI W.: "Disappeareance of psoriatic skin rashes in the course of atropine therapy", POL TYG LEK, vol. 25, no. 47, November 1970 (1970-11-01), pages 1815 - 1816 *
KLAPPROTH H. ET AL: "Non-neuronal acetylcholine, a signalling molecule synthezised by surface cells of rat and man", NAUNYN-SCHMIEDEBERG'S ARCH. PHARMACOL., vol. 355, no. 4, April 1997 (1997-04-01), pages 515 - 523, XP002047241 *
KLAPPROTH H. ET AL: "Non-neuronal acetylcholine, a widespread signalling molecule in man", BRITISH JOURNAL OF PHARMACOLOGY, vol. 120, March 1997 (1997-03-01), pages 61P, XP002047240 *
REINHEIMER T. ET AL: "Acetylcholine in isolated airways of rat, guinea pig, and human: species differences in role of airway mucosa", AM. J. PHYSIOL. (UNITED STATES), vol. 14, no. 5, May 1996 (1996-05-01), pages L722 - L728, XP002047238 *

Also Published As

Publication number Publication date
WO1998000119A2 (de) 1998-01-08
AU3263297A (en) 1998-01-21
ZA975804B (en) 1998-01-02
DE19626373A1 (de) 1998-01-08

Similar Documents

Publication Publication Date Title
CA2180950A1 (en) Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof
AU3689595A (en) Device for use in the laser treatment of biological tissue (variants thereof)
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
CA2311696A1 (en) Self-tanning composition comprising carmine
CA2180816A1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
CA2193337A1 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
DE69638351D1 (de) Sowie zur resektion des distalen und vorderen femurs
WO1996028008A3 (fr) Compositions cosmetiques et dermatologiques pour lutter contre le vieillissement de la peau
EP2213302A3 (de) DR4-Antikörper und Verwendungen dafür
CA2132369A1 (en) Use for the Treatment of Mixed Skins, of an Effective Quantity of Active Substances
CA2359354A1 (en) Medicament for the treatment, prevention and diagnosis of infection due to chlamydia pneumoniae
AU7629694A (en) Compositions for treating corns, calluses and warts
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
WO1998000119A3 (de) Verwendungen von wirkstoffen, welche die funktionen von nicht-neuronalem acetylcholin beeinflussen
WO2001045650A3 (de) Kosmetische verwendung von rückständen aus der weinherstellung
HRP970292A2 (en) Substituted 2-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them
AU5539798A (en) Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
CA2322027A1 (en) Use of macrolide compounds for the treatment of ards
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
ZA976735B (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them.
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
WO1999045894A3 (en) Cosmetic compositions
AU2371397A (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
AU2001296477A1 (en) Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BG BR BY CA CN CZ EE HU IL JP KR KZ LT LV MX NO NZ PL RO RU SG SI SK TR UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BG BR BY CA CN CZ EE HU IL JP KR KZ LT LV MX NO NZ PL RO RU SG SI SK TR UA US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97532940

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase